1,4-Dioxane hydrochloride → HCID 178462017、化合物

HRID 1691768ノート

反応式

HRID 1691768 の反応式
[F:1][C:2]1[CH:7]=[C:6]([C:8]2[NH:12][N:11]=[N:10][N:9]=2)[CH:5]=[C:4]([F:13])[C:3]=1[N:14]1[CH2:19][CH2:18][CH:17]([CH2:20][N:21]([C@@H:29]([C:31]2[C:40]3[C:35](=[CH:36][CH:37]=[CH:38][CH:39]=3)[CH:34]=[CH:33][CH:32]=2)[CH3:30])C(=O)OC(C)(C)C)[CH:16]([C:41]2[CH:46]=[CH:45][CH:44]=[CH:43][CH:42]=2)[CH2:15]1.Cl.O1CCOCC1>>[F:13][C:4]1[CH:5]=[C:6]([C:8]2[NH:12][N:11]=[N:10][N:9]=2)[CH:7]=[C:2]([F:1])[C:3]=1[N:14]1[CH2:19][CH2:18][CH:17]([CH2:20][NH:21][C@@H:29]([C:31]2[C:40]3[C:35](=[CH:36][CH:37]=[CH:38][CH:39]=3)[CH:34]=[CH:33][CH:32]=2)[CH3:30])[CH:16]([C:41]2[CH:42]=[CH:43][CH:44]=[CH:45][CH:46]=2)[CH2:15]1

参加物

3

反応物 2

HCID 204431481,4-Dioxane hydrochlorideHCID 178461650HCID 178461650、化合物

生成物 1

HCID 178462017HCID 178462017、化合物収率 91.8%

実験手順

To 205 mg of tert-butyl ({1-[2,6-difluoro-4-(1H-tetrazole-5-yl)phenyl]-3-phenylpiperidin-4-yl}methyl)[(1R)-1-(1-naphthyl)ethyl]carbamate was added 2.0 mL of a 4 M hydrogen chloride/1,4-dioxane solution, followed by stirring at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, and to the residue was then added a saturated aqueous sodium hydrogen carbonate solution, followed by extraction with chloroform. The organic layer was dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (chloroform/methanol) to obtain 158 mg of (1R)—N-({1-[2,6-difluoro-4-(1H-tetrazol-5-yl)phenyl]-3-phenylpiperidin-4-yl}methyl)-1-(1-naphthyl)ethaneamine. 2.0 mL of hydrogen chloride/1,4-dioxane solution was added thereto, followed by concentration under reduced pressure, and to the obtained residue was then added about 3 mL of isopropanol, followed by heating. The mixture was left to be cooled to room temperature, and the precipitate was collected by filtration, and dried under reduced pressure to obtain 153 mg of (1R)—N-({1-[2,6-difluoro-4-(1H-tetrazol-5-yl)phenyl]-3-phenylpiperidin-4-yl}methyl)-1-(1-naphthyl)ethaneamine hydrochloride as a white solid.

後処理

  1. concentrationThe reaction mixture was concentrated under reduced pressure
  2. additionto the residue was then added a saturated aqueous sodium hydrogen carbonate solution
  3. extractionfollowed by extraction with chloroform
  4. dry with materialThe organic layer was dried over anhydrous sodium sulfate
  5. filtrationAfter filtration
  6. concentrationthe filtrate was concentrated under reduced pressure
  7. customthe residue was purified by silica gel column chromatography (chloroform/methanol)

出典と根拠

ORDレコード
ord-57b854d694b54dee9f569e99a4eacd3b
出典データセット
uspto-grants-2012_04
特許番号
US08153658B2

反応ノート

読み込み中…